title: Therapeutic uses of microencapsulated genetically engineered cells.
abstract: Microencapsulated genetically engineered cells have the potential to treat a wide range of diseases. For example, in experimental animals, implanted microencapsulated cells have been used to secrete growth hormone to treat dwarfism, neurotrophic factors for amyotrophic lateral sclerosis, beta-endorphin to decrease pain, factor XI for hemophilia B, and nerve growth factors to protect axotomized neurons. For some applications, microencapsulated cells can even be given orally. They can be engineered to remove unwanted molecules from the body as they travel through the intestine, and are finally excreted in the stool without being retained in the body. This application has enormous potential for the removal of urea in kidney failure, ammonia in liver failure and amino acids such as phenylalanine in phenylketonuria and other inborn errors of metabolism.
authors.affiliation: Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, QC, Canada.
authors.forename: T M
authors.initials: TM
authors.lastname: Chang
authors.forename: S
authors.initials: S
authors.lastname: Prakash
mesh_terms: D000818:Animals; D001709:Biotechnology; D002214:Capsules; D017690:Cell Transplantation; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D051381:Rats; D051437:Renal Insufficiency / Q000628:therapy
chemical_list: D002214:Capsules